Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biozoomer is a health technology company specializing in non-invasive optical biomarker measurement and biological age testing. Utilizing proprietary reflection spectroscopy technology, the company's devices analyze skin biomarkers to provide real-time insights into antioxidant levels, oxidative stress, and overall metabolic health. Their platform is designed for both clinical and consumer use, enabling personalized health monitoring and the assessment of lifestyle and nutritional interventions. Biozoomer's solutions are primarily focused on preventative healthcare, wellness, and longevity. The company's technology has been validated through collaborations with academic institutions like Charité Berlin. By providing immediate, actionable health data, Biozoomer aims to empower individuals to optimize their well-being and track the aging process.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biozoomer.